Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer's Disease: An Educational Literature Review
Mostafa Hossam El Din Moawad,Ibrahim Serag,Ibraheem M. Alkhawaldeh,Abdallah Abbas,Abdulrahman Sharaf,Sumaya Alsalah,Mohammed Ahmed Sadeq,Mahmoud Mohamed Mohamed Shalaby,Mahmoud Tarek Hefnawy,Mohamed Abouzid,Mostafa Meshref
DOI: https://doi.org/10.1007/s12035-024-04468-y
IF: 5.682
2024-09-12
Molecular Neurobiology
Abstract:Alzheimer's disease (AD) presents a significant challenge to global health. It is characterized by progressive cognitive deterioration and increased rates of morbidity and mortality among older adults. Among the various pathophysiologies of AD, mitochondrial dysfunction, encompassing conditions such as increased reactive oxygen production, dysregulated calcium homeostasis, and impaired mitochondrial dynamics, plays a pivotal role. This review comprehensively investigates the mechanisms of mitochondrial dysfunction in AD, focusing on aspects such as glucose metabolism impairment, mitochondrial bioenergetics, calcium signaling, protein tau and amyloid-beta-associated synapse dysfunction, mitophagy, aging, inflammation, mitochondrial DNA, mitochondria-localized microRNAs, genetics, hormones, and the electron transport chain and Krebs cycle. While lecanemab is the only FDA-approved medication to treat AD, we explore various therapeutic modalities for mitigating mitochondrial dysfunction in AD, including antioxidant drugs, antidiabetic agents, acetylcholinesterase inhibitors (FDA-approved to manage symptoms), nutritional supplements, natural products, phenylpropanoids, vaccines, exercise, and other potential treatments.
neurosciences